Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e18cb2605e5cd7d5405b439521d021d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
filingDate |
2011-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a846c6b6856dd61f83d573cd2a3b2b4a |
publicationDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8597654-B2 |
titleOfInvention |
Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod |
abstract |
The present application describes adjuvant therapy of nonmetastatic breast cancer using an anti-ErbB2 antibody conjugated to a maytansinoid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849849-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655305-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654105-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689457-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638756-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940302-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597776-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969811-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414498-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9815904-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9181346-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077189-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014341886-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017671-B2 |
priorityDate |
2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |